Merck & Co. (NYSE:MRK) Acquires Amptec To Enhance its mRNA manufacturing Capabilities With its PCR Tech
Merck & Co. (NYSE:MRK) has announced the acquisition of the leading mRNA contract development and manufacturing organization (CDM)), Amptec. The
Read more